Evidence map›Paper›PMID 40849653›Full record

ArticleImplementation science communications2025

Tempering implementation optimism: distinguishing between efficacy and effectiveness in implementation research.

Per Nilsen, Jeanette Wassar Kirk, Katarina Ulfsdotter Gunnarsson, Kristin Thomas

Abstract read
In one paragraph

Article in Implementation science communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Per NilsenDepartment of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden. per.nilsen@liu.se.ORCID http://orcid.org/0000-0003-0657-9079
Jeanette Wassar KirkDepartment of Clinical Research, Hvidovre University Hospital, Copenhagen, Denmark.
Katarina Ulfsdotter GunnarssonDepartment of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Kristin ThomasDepartment of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe distinction between efficacy (performance under ideal conditions) and effectiveness (performance in real-world settings) is well established in intervention research. Intervention effectiveness is often used as a proxy for implementation readiness. However, relying on this assumption can lead to overly optimistic expectations about real-world outcomes if the complexities of routine practice settings are not adequately considered. MAIN BODY: This paper introduces the distinction between implementation efficacy (implementation strategy performance under controlled or highly supported conditions) and implementation effectiveness (performance under typical, resource-constrained settings). We argue that the efficacy-effectiveness distinction is as critical for implementation research as it is for intervention research. Recognizing and systematically operationalizing this distinction can sharpen conceptual clarity, strengthen research design and enhance the relevance and generalizability of findings for real-world application. Yet despite its importance, this distinction is rarely made explicit in implementation studies. Research often fails to specify the conditions under which implementation strategies are investigated; studies can vary widely in how closely they reflect routine practice. Compounding this issue, economic evaluations remain uncommon in implementation research. However, without systematic assessment of resource use, it is difficult to determine whether reported implementation outcomes have been achieved through contextually feasible strategies or through intensive supports, such as dedicated staffing, external facilitation, or financial incentives, which are rarely available in everyday practice. To address this gap, we propose adapting the PRECIS-2 (Pragmatic Explanatory Continuum Indicator Summary 2) framework from clinical trials into an "Implementation PRECIS" tool. An adapted version of PRECIS-2 for implementation research could offer a systematic way to describe the extent to which a study reflects idealized conditions versus real-world practice.

conclusionClarifying whether implementation strategies are studied under efficacy-like or effectiveness-like conditions enhances research design, interpretation, and communication with stakeholders. It also supports informed decisions about replication and scale-up. By embracing this distinction, implementation research can temper overly optimistic assumptions, better reflect real-world constraints, and contribute more meaningfully to evidence-based practice. We argue that making this distinction explicit is a necessary step toward a more pragmatic and transparent science of implementation.

Indexed as

EffectivenessEfficacyStrategies

Identifiers

PMID40849653
PMCPMC12374263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.